Corporate News     11-Feb-21
Board of Suvan Pharmaceuticals recommends Interim Dividend
Of Rs.1 per share
Suvan Pharmaceuticals announced that the Board of Directors of the Company at its meeting held on 10 February 2021, has recommended a Interim dividend of Rs.1 per share (i.e.100%), subject to the approval of the shareholders.
Previous News
  Suven Pharmaceuticals consolidated net profit declines 25.70% in the September 2022 quarter
 ( Results - Announcements 08-Nov-22   13:39 )
  Suven Pharmaceuticals consolidated net profit declines 49.61% in the June 2024 quarter
 ( Results - Announcements 09-Aug-24   16:00 )
  Suven Pharmaceuticals consolidated net profit rises 40.87% in the December 2021 quarter
 ( Results - Announcements 08-Feb-22   13:59 )
  Volumes spurt at Avanti Feeds Ltd counter
 ( Hot Pursuit - 14-Sep-23   14:30 )
  Suven Pharmaceuticals consolidated net profit rises 96.22% in the December 2020 quarter
 ( Results - Announcements 12-Feb-21   17:54 )
  Suven Pharmaceuticals consolidated net profit rises 2.34% in the June 2022 quarter
 ( Results - Announcements 08-Aug-22   14:55 )
  Board of Suven Pharmaceuticals appoints Chairman
 ( Corporate News - 08-Feb-22   15:53 )
  Suven Pharmaceuticals to table results
 ( Corporate News - 03-Aug-23   14:27 )
  Board of Suven Pharmaceuticals approves evaluation of an acquisition opportunity
 ( Corporate News - 08-Feb-22   15:42 )
  Suven Pharma to manufacture anti-covid drugs Molnupiravir and 2-DG
 ( Corporate News - 10-Jun-21   17:27 )
  Suven Pharmaceuticals consolidated net profit rises 12.14% in the June 2023 quarter
 ( Results - Announcements 09-Aug-23   07:43 )
Other Stories
  CARE reaffirms ratings on bank facilities of PNC Infratech's subsidiaries
  05-Oct-24   10:45
  CG Power & Industrial Solutions to acquire radio frequency components biz of Renesas
  05-Oct-24   10:30
  MMP Industries to convene board meeting
  05-Oct-24   10:23
  Mahindra & Mahindra Financial Serv. to discuss results
  05-Oct-24   10:23
  Ambey Laboratories to hold board meeting
  05-Oct-24   10:23
  Aurobindo Pharma's step down subsidiary to divest its entire stake in JV 'Novagen'
  05-Oct-24   10:21
  Aurobindo Pharma's step down subsidiary to divest its entire stake in a South African JV
  05-Oct-24   10:19
  Just Dial announces board meeting date
  05-Oct-24   10:11
  L&T Finance schedules board meeting
  05-Oct-24   10:11
  Australian Premium Solar (India) announces board meeting date
  05-Oct-24   10:11
Back Top